Pharmaceutical Filtration Market by Product (Membrane Filters, Single-Use Systems), Technique (Microfiltration, Ultrafiltration), Application (Final Product Processing, Raw material), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2021
[164 Pages Report] The global pharmaceutical filtration market is poised to reach USD 22.71 Billion by 2021 from USD 13.73 Billion in 2016, at a CAGR of 10.6% from 2016 to 2021.
The global market for pharmaceutical filtration is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the market for pharmaceutical filtration is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products. In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.
Market Dynamics
Growth in the production of biologics and large molecules
Biopharmaceuticals are one of the fastest-growing segments in the pharmaceutical industry; filtration finds widespread application in the biopharmaceuticals industry. As estimated by QuintilesIMS, the global pharmaceutical spending is expected to grow to nearly USD 1.4 trillion by 2020. The share of biopharmaceutical products in the global pharmaceutical market is expected to increase from 23% in 2014 to 27% in 2020. The growing share can be attributed to the increased usage of cell therapy, gene therapy, and recombinant therapeutics for the treatment of various diseases and disorders such as rheumatoid arthritis, diabetes, and malignancy. According to the Tufts Center for the Study of Drug Development, biotech products accounted for 71% of the revenue generated by the top 10 products in 2012. Furthermore, the looming patent cliff and effective treatment offered by biologics is compelling most pharmaceutical companies to develop new biologics.
Biologics are genetically engineered proteins composed of sugars, nucleic acids, or even cells and tissue. They have helped transform the treatment of life-threatening, debilitating diseases. The biologics pipeline has increased by 155%from 355 treatments in 2001 to 907 in 2012 (Source: Tufts University). Hundreds of biologics, such as monoclonal antibodies (mAbs), are either currently launched in the market or under development. With the prominence of mAbs as therapeutic agents, many companies have multiple antibodies in their development pipeline. Various purification processes are employed in the recovery of different products that can be used to purify molecules with minimal process alterations, where filtration plays an important role. Among the biologics, monoclonal antibodies comprise a major share (26.3%), followed by vaccines (17.5%).
Another important indicator for the growth of the biopharmaceutical industry is the number of biotechnology and pharmaceutical patents granted worldwide. According to the World Intellectual Property Organization (WIPO), about 50,423 biotechnology and 90,242 pharmaceutical patents were filed worldwide in 2014. Increased R&D spending by pharmaceutical and biotechnology companies and government support for the same will aid the growth of pharmaceutical filtration market.
Stringent government regulations for the validation of filtration processes
Pharmaceutical and biotechnology companies face various challenges in obtaining FDA approvals for new and innovative products. The validation of filtration processes helps ensure that the process can perform consistently without any failure. In the U.S., the FDA provides Quality by Design (QbD) principles, through which the filtration process is designed. This validates the use of pharmaceutical filters. In Canada, Health Canada regulates the use of pharmaceutical filters with the help of GMP guidelines. The Parenteral Drug Association (PDA) (U.S.) compiles technical information on validations or equipment qualification, process development, process validation, cleaning validation, and membrane reuse of pharmaceutical filtration equipment globally.
The U.S. FDA provides Current Good Manufacturing Practice (CGMP) regulations for the processing of drugs and biologics. The 21 Code of Federal Regulation (21 CFR) part 211 provides qualifications on installation, operation, and performance of pharmaceutical equipment. This regulation prohibits the use of asbestos-containing filters for the production of injectable drug products.
A similar trend of increased regulatory stringency is observed in Europe. The filtration industry in Europe has introduced a new standard (owing to the formulation of EN 779:2011) for specific air filters used for pharmaceutical filtration applications. This new standard is likely to eradicate filtration performance issues related to time. Stringent regulatory frameworks and time-consuming approval processes may deter research investments in this market and delay new product launches.
Based on technique, the microfiltration segment dominated this market in 2016. The technique is applied to various applications ranging from the removal of unwanted suspensions to the removal of bacteria from the process material. This is the major factor responsible for the large share of this segment.
Based on application, the final product-processing segment is expected to register the highest CAGR during the forecast period owing to the rapidly growing biologics and generic drug production coupled with the presence of stringent regulatory guidelines to maintain a clean and safe manufacturing environment.
Based on scale of operation, the manufacturing scale segment is expected to register the highest growth during the forecast period. The high growth in this segment can primarily be attributed to the growth in the biopharmaceutical industry coupled with the outsourcing of pharmaceutical and biopharmaceutical production in emerging countries.
Growth in the global pharmaceutical filtration industry is primarily driven by factors such as growth in the production of biologics and generics, technological advancements in filters, and the requirement for cleanroom research and manufacturing. Other factors supporting market growth include an increase in R&D spending by pharmaceutical and biopharmaceutical companies and a strong biologics pipeline. The emerging markets are also expected to offer plenty of growth opportunities for players in the market. The huge capital required to set up new production facilities and stringent government regulations to validate the filtration process are expected to limit market growth to a certain extent.
The market is dominated by established players such as Merck KGaA (Germany), GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), and Sartorius Stedim Biotech S.A. (France).
Stakeholders
- Filters Manufacturers, Vendors, and Distributors
- Academic and Government Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Market Research & Consulting Firms
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
Scope of the Pharmaceutical Filtration Market report includes the following:
Market Segmentation
This research report categorizes the market on the basis of product, technique, application, scale of operation, and region
Global Pharmaceutical Filtration Market, by Product
- Membrane Filters
- MCE Membrane Filters
- Coated Cellulose Acetate Membrane Filters
- Nylon Membrane Filters
- PTFE Membrane Filters
- PVDF Membrane Filters
- Other Membrane Filters (Polyethersulfone (PES), polypropylene (PP), polycarbonate track-etched (PCTE), and regenerated cellulose (RC) membrane filters)
- Prefilters and Depth Media Filters
- Glass Fiber Filters
- PTFE Fiber Filters
- Single-use Systems
- Cartridge & Capsule Filters
- Filter Holders
- Filtration Accessories
- Other Products (Syringe filters, filter bags, and cartridge housing equipment)
Global Pharmaceutical Filtration Market, by Technique
- Microfiltration
- Ultrafiltration
- Nanofiltration
- Other techniques (Ion exchange, reverse osmosis)
Global Pharmaceutical Filtration Market, by Application
- Final Product Processing
- API Filtration
- Sterile Filtration
- Protein Purification
- Vaccine and Antibody Processing
- Formulation and Filling Solution Filtration
- Viral Clearance
- Raw Material Filtration
- Media & Buffer filtration
- Prefiltration
- Bioburden Testing
- Cell Separation
- Water Purification
- Air Purification
Global Pharmaceutical Filtration Market, by Scale of Operation
- Manufacturing Scale
- Pilot Scale
- R&D Scale
Global Pharmaceutical Filtration Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Rest of Europe (RoE)
- Asia
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the companys specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
The global pharmaceutical filtration market is projected to reach USD 22.71 Billion by 2021 from USD 13.73 Billion in 2016, at a CAGR of 10.6% during the forecast period.
Growth in the market for pharmaceutical filtration is primarily driven by factors such as growth in the production of biopharmaceuticals, technological advancements in filtration equipment, and rapid growth in generics production. Other factors supporting market growth include an increase in R&D spending by biopharmaceutical companies leading to a strong biologics pipeline and government mandates to have a clean and safe research and manufacturing environment. In addition, growing adoption of pharmaceutical filters in the lucrative emerging markets is expected to offer growth opportunities for manufacturers of pharmaceutical filtration solutions. However, huge capital investments required to set up new production facilities is restraining the growth of this market.
The global pharmaceutical filtration market is segmented on the basis of product, technique, application, scale of operation, and region. On the basis of product, the market for pharmaceutical filtration is segmented into membrane filters, prefilters and depth media filters, cartridge & capsule filters, single-use systems, filter holders, filtration accessories, and other products. In 2016, the membrane filters segment accounted for the largest share of the market. This segment is also expected to register the highest CAGR during the forecast period. The key factor driving the growth of the membrane filters segment is the ease of installation in large and small manufacturing facilities owing to the availability of a variety of pore and surface types.
Based on technique, the microfiltration segment dominated this market in 2016. The technique is applied to various applications ranging from the removal of unwanted suspensions to the removal of bacteria from the process material. This is the major factor responsible for the large share of this segment.
Based on application, the final product-processing segment is expected to register the highest CAGR during the forecast period owing to the rapidly growing biologics and generic drug production coupled with the presence of stringent regulatory guidelines to maintain a clean and safe manufacturing environment.
Based on scale of operation, the manufacturing scale segment is expected to register the highest growth during the forecast period. The high growth in this segment can primarily be attributed to the growth in the biopharmaceutical industry coupled with the outsourcing of pharmaceutical and biopharmaceutical production in emerging countries.
North America accounted for the largest share of the pharmaceutical filtration market in 2016. The growing biopharmaceutical industry and the presence of a large number of market players are propelling the growth of the North American market. However, the Asian region is estimated to witness the highest growth during the forecast period. In recent years, the Asian market for pharmaceutical filtration is witnessing significant growth owing to the rapid growth in generic drug production, increasing number of contract research and manufacturing organizations, and increasing focus of international players in emerging markets.
Major players operating in the Pharmaceutical Filtration Market include Merck KGaA (Germany), GE Healthcare (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), and Sartorius Stedim Biotech S.A. (France).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.2.1 Key Industry Insights
2.3.3 Assumptions for the Study
3 Executive Summary (Page No. - 25)
4 Premium Insights (Page No. - 30)
4.1 Pharmaceutical Filtration: Market Overview
4.2 Geographic Analysis: Pharmaceutical Filtration Market, By Technique (2016)
4.3 Market: Geographic Growth Opportunities
4.4 Market for Final Product Processing, By Type, 2016 vs 2021
4.5 Pharmaceutical Membrane Filters Market Size, By Type, 2016 vs 2021
5 Industry Insights (Page No. - 34)
5.1 Introduction
5.2 Supply Chain Analysis
5.3 Regulatory Scenario
5.3.1 Major Stakeholders
5.3.2 Key Influencers
5.4 Industry Trends
5.4.1 Increasing Adoption of Single-Use Technologies
5.4.2 Channel Optimization
6 Pharmaceutical Filtration Market Overview (Page No. - 39)
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Growth in the Production of Biologics and Large Molecules
6.2.1.2 Advancements in the Nanofiber Technology
6.2.1.3 Rapid Growth in Generic Drug Production
6.2.1.4 Need for Clean and Safe Research and Manufacturing Environment
6.2.2 Restraints
6.2.2.1 Stringent Government Regulations for the Validation of Filtration Processes
6.2.3 Opportunities
6.2.3.1 Emerging Markets Offer Lucrative Growth Opportunities
6.2.4 Challenges
6.2.4.1 Huge Capital Investments Required to Set Up New Production Facilities
7 Pharmaceutical Filtration Market, By Product (Page No. - 45)
7.1 Introduction
7.2 Membrane Filters
7.2.1 MCE Membrane Filters
7.2.2 Coated Cellulose Acetate Membrane Filters
7.2.3 PTFE Membrane Filters
7.2.4 Nylon Membrane Filters
7.2.5 PVDF Membrane Filters
7.2.6 Other Membrane Filters
7.3 Prefilters & Depth Media Filters
7.3.1 Glass Fiber Filters
7.3.2 PTFE Fiber Filters
7.4 Single-Use Systems
7.5 Cartridge & Capsule Filters
7.6 Filter Holders
7.7 Filtration Accessories
7.8 Other Products
8 Pharmaceutical Filtration Market, By Technique (Page No. - 63)
8.1 Introduction
8.2 Microfiltration
8.3 Ultrafiltration
8.4 Nanofiltration
8.5 Other Techniques
9 Pharmaceutical Filtration Market, By Application (Page No. - 69)
9.1 Introduction
9.2 Final Product Processing
9.2.1 Active Pharmaceutical Ingredient Filtration
9.2.2 Sterile Filtration
9.2.3 Protein Purification
9.2.4 Vaccine and Antibody Processing
9.2.5 Formulation and Filling Solution Filtration
9.2.6 Viral Clearance
9.3 Raw Material Filtration
9.3.1 Media and Buffer Filtration
9.3.2 Prefiltration
9.3.3 Bioburden Testing
9.4 Cell Separation
9.5 Water Purification
9.6 Air Purification
10 Pharmaceutical Filtration Market, By Scale of Operation (Page No. - 82)
10.1 Introduction
10.2 Manufacturing-Scale Operations
10.3 Pilot-Scale Operations
10.4 R&D-Scale Operations
11 Pharmaceutical Filtration Market, By Region (Page No. - 87)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 U.K.
11.3.3 Rest of Europe (RoE)
11.4 Asia
11.5 Rest of the World
12 Competitive Landscape (Page No. - 116)
12.1 Introduction
12.2 Strategic Analysis
12.3 Market Share Analysis
12.4 Competitive Situation and Trends
12.4.1 Product Launches
12.4.2 Acquisitions
12.4.3 Expansions
12.4.4 Agreements and Collaborations
12.4.5 Other Strategies
13 Company Profiles (Page No. - 125)
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Introduction
13.2 Merck KGaA
13.3 GE Healthcare
13.4 Pall Corporation
13.5 Parker Hannifin Corporation
13.6 Sartorius Stedim Biotech S.A.
13.7 3M Company
13.8 Eaton Corporation PLC
13.9 Amazon Filters Ltd.
13.10 Graver Technologies, LLC
13.11 Meissner Filtration Products, Inc.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. - 154)
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details
List of Tables (87 Tables)
Table 1 Pharmaceutical Filtration Market Size, By Product, 20142021 (USD Million)
Table 2 Market For Pharmaceutical Filtration: Size for Membrane Filters, By Type, 20142021 (USD Million)
Table 3 Market Size for Membrane Filters, By Region, 20142021 (USD Million)
Table 4 Market Size for MCE Membrane Filters, By Region, 20142021 (USD Million)
Table 5 Market Size for Coated Cellulose Acetate Membrane Filters, By Region, 20142021 (USD Million)
Table 6 Market Size for PTFE Membrane Filters, By Region, 20142021 (USD Million)
Table 7 Market Size for Nylon Membrane Filters, By Region, 20142021 (USD Million)
Table 8 Market Size for PVDF Membrane Filters, By Region, 20142021 (USD Million)
Table 9 Market Size for Other Membrane Filters, By Region, 20142021 (USD Million)
Table 10 Pharmaceutical Filtration Market Size for Prefilters & Depth Media Filters, By Type, 20142021 (USD Million)
Table 11 Market Size for Prefilters & Depth Media Filters, By Region, 20142021 (USD Million)
Table 12 Market For Pharmaceutical Filtration: Size for Glass Fiber Filters, By Region, 20142021 (USD Million)
Table 13 Market Size for PTFE Fiber Filters, By Region, 20142021 (USD Million)
Table 14 Market For Pharmaceutical Filtration: Size for Single-Use Systems, By Region, 20142021 (USD Million)
Table 15 Market Size for Cartridge & Capsule Filters, By Region, 20142021 (USD Million)
Table 16 Market For Pharmaceutical Filtration: Size for Filter Holders, By Region, 20142021 (USD Million)
Table 17 Pharmaceutical Filtration Accessories Market Size, By Region, 20142021 (USD Million)
Table 18 Other Pharmaceutical Filtration Products Market Size, By Region, 20142021 (USD Million)
Table 19 Market Size, By Technique, 20142021 (USD Million)
Table 20 Pharmaceutical Microfiltration Market Size, By Region, 20142021 (USD Million)
Table 21 Pharmaceutical Ultrafiltration Market Size, By Region, 20142021 (USD Million)
Table 22 Pharmaceutical Nanofiltration Market Size, By Region, 20142021 (USD Million)
Table 23 Other Pharmaceutical Filtration Techniques Market Size, By Region, 20142021 (USD Million)
Table 24 Market Size, By Application, 20142021 (USD Million)
Table 25 Final Product Processing Market Size, By Type, 20142021 (USD Million)
Table 26 Final Product Processing Market Size, By Region, 20142021 (USD Million)
Table 27 API Filtration Market Size, By Region, 20142021 (USD Million)
Table 28 Sterile Filtration Market Size, By Region, 20142021 (USD Million)
Table 29 Protein Purification Market Size, By Region, 20142021 (USD Million)
Table 30 Vaccine and Antibody Processing Market Size, By Region, 20142021 (USD Million)
Table 31 Formulation and Filling Solution Filtration Market Size, By Region, 20142021 (USD Million)
Table 32 Viral Clearance Market Size, By Region, 20142021 (USD Million)
Table 33 Raw Material Filtration Market Size, By Type, 20142021 (USD Million)
Table 34 Raw Material Filtration Market Size, By Region, 20142021 (USD Million)
Table 35 Pharmaceutical Filtration Market Size for Media and Buffer Filtration, By Region, 20142021 (USD Million)
Table 36 Market Size for Prefiltration, By Region, 20142021 (USD Million)
Table 37 Market Size for Bioburden Testing, By Region, 20142021 (USD Million)
Table 38 Cell Separation Market Size, By Region, 20142021 (USD Million)
Table 39 Water Purification Market Size, By Region, 20142021 (USD Million)
Table 40 Air Purification Market Size, By Region, 20142021 (USD Million)
Table 41 Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 42 Pharmaceutical Filtration Market Size for Manufacturing-Scale Operations, By Region, 20142021 (USD Million)
Table 43 Market Size for Pilot-Scale Operations, By Region, 20142021 (USD Million)
Table 44 Market Size for R&D-Scale Operations, By Region, 20142021 (USD Million)
Table 45 Market Size, By Region, 20142021 (USD Million)
Table 46 North America: Pharmaceutical Filtration Market Size, By Region, 20142021 (USD Million)
Table 47 North America: Market Size, By Product, 20142021 (USD Million)
Table 48 North America: Market For Pharmaceutical Filtration: Size, By Technique, 20142021 (USD Million)
Table 49 North America: Market Size, By Application, 20142021 (USD Million)
Table 50 North America: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 51 U.S.: Market Size, By Product, 20142021 (USD Million)
Table 52 U.S.: Market Size, By Technique, 20142021 (USD Million)
Table 53 U.S.: Market Size, By Application, 20142021 (USD Million)
Table 54 U.S.: Market Size, By Scale of Operation, 20142021 (USD Million)
Table 55 Canada: Pharmaceutical Filtration Market Size, By Product, 20142021 (USD Million)
Table 56 Canada: Market Size, By Technique, 20142021 (USD Million)
Table 57 Canada: Market Size, By Application, 20142021 (USD Million)
Table 58 Canada: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 59 Europe: Market Size, By Product, 20142021 (USD Million)
Table 60 Europe: Market Size, By Technique, 20142021 (USD Million)
Table 61 Europe: Market Size, By Application, 20142021 (USD Million)
Table 62 Europe: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 63 Germany: Pharmaceutical Filtration Market Size, By Product, 20142021 (USD Million)
Table 64 Germany: Market Size, By Technique, 20142021 (USD Million)
Table 65 Germany: Market Size, By Application, 20142021 (USD Million)
Table 66 Germany: Market Size, By Scale of Operation, 20142021 (USD Million)
Table 67 U.K.: Market Size, By Product, 20142021 (USD Million)
Table 68 U.K.: Market Size, By Technique, 20142021 (USD Million)
Table 69 U.K.: Market Size, By Application, 20142021 (USD Million)
Table 70 U.K.: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 71 RoE: Pharmaceutical Filtration Market Size, By Product, 20142021 (USD Million)
Table 72 RoE: Market Size, By Technique, 20142021 (USD Million)
Table 73 RoE: Market Size, By Application, 20142021 (USD Million)
Table 74 RoE: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 75 Asia: Market Size, By Product, 20142021 (USD Million)
Table 76 Asia: Market Size, By Technique, 20142021 (USD Million)
Table 77 Asia: Market For Pharmaceutical Filtration: Size, By Application, 20142021 (USD Million)
Table 78 Asia: Pharmaceutical Filtration Market Size, By Scale of Operation, 20142021 (USD Million)
Table 79 RoW: Market Size, By Product, 20142021 (USD Million)
Table 80 RoW: Market Size, By Technique, 20142021 (USD Million)
Table 81 RoW: Market Size, By Application, 20142021 (USD Million)
Table 82 RoW: Market For Pharmaceutical Filtration: Size, By Scale of Operation, 20142021 (USD Million)
Table 83 Product Launches, 20142016
Table 84 Acquisitions, 20142016
Table 85 Expansions, 20142016
Table 86 Agreements and Collaborations, 20142016
Table 87 Other Strategies, 20142016
List of Figures (36 Figures)
Figure 1 Pharmaceutical Filtration Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Pharmaceutical Filtration Market, By Product, 2016 vs 2021 (USD Billion)
Figure 8 Market, By Technique, 2016 vs 2021 (USD Billion)
Figure 9 Market, By Application, 2016 vs 2021 (USD Billion)
Figure 10 Market, By Scale of Operation, 2016 vs 2021 (USD Billion)
Figure 11 Asia Region to Register Highest Growth During the Forecast Period
Figure 12 Global Pharmaceutical Filtration Market to Witness A Double-Digit Growth Rate During the Forecast Period
Figure 13 Microfiltration Segment Commanded the Largest Share of the Pharmaceutical Filtration Market in 2016
Figure 14 Asia to Register the Highest CAGR in the Forecast Period
Figure 15 Active Pharmaceutical Ingredient Filtration Segment Dominated the Final Product Processing Market in 2016
Figure 16 Mixed Cellulose Ester (MCE) Dominated the Pharmaceutical Membrane Filters Market in 2016
Figure 17 Supply Chain Analysis: Pharmaceutical Filtration Equipment Industry (As of 2016)
Figure 18 Pharmaceutical Filtration Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Market Segmentation, By Product
Figure 20 Market For Pharmaceutical Filtration: Segmentation, By Technique
Figure 21 Market Segmentation, By Application
Figure 22 Market For Pharmaceutical Filtration: Segmentation, By Scale of Operation
Figure 23 Market in Asia to Grow at the Highest Rate (2016 to 2021)
Figure 24 North America: Pharmaceutical Filtration Market Snapshot
Figure 25 Asia: Market For Pharmaceutical Filtration: Snapshot
Figure 26 Key Developments Registered By Leading Players in the Pharmaceutical Filtration Market, 20142016
Figure 27 Market Share Analysis, By Key Player, 2015
Figure 28 Battle for Market Share: Product Launches Was the Most Widely Adopted Growth Strategy Between 2014 & 2016
Figure 29 Geographic Revenue Mix of the Top Five Market Players
Figure 30 Company Snapshot: Merck KGaA (2015)
Figure 31 Company Snapshot: GE Healthcare (2015)
Figure 32 Company Snapshot: Danaher Corporation (2015)
Figure 33 Company Snapshot: Parker Hannifin Corporation (2016)
Figure 34 Company Snapshot: Sartorius Stedim Biotech S.A. (2016)
Figure 35 Company Snapshot: 3M Company (2015)
Figure 36 Company Snapshot: Eaton Corporation (2015)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Filtration Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Pharmaceutical Filtration Market